secwatch.observer — SEC 8-K summary
======================================

Issuer:     IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK:        0001425205
Form:       8-K
Filed at:   2026-08-06T21:30:35+00:00
Accession:  0001104659-26-092145
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iovance updates corporate presentation; no specific new data in filing text
---------------------------------------------------------------------------

- Corporate presentation updated for August 2026; used at healthcare conferences and with analysts.
- No specific financial results, guidance, or operational milestones disclosed in the filing.
- Exhibit 99.1 (presentation) is referenced but its content is not available in the provided text.
- Confidence in materiality is low due to lack of exhibit content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425205/000110465926092145/0001104659-26-092145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425205/000110465926092145/tm2622463d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-092145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer